Evinature is a science-first nutraceutical company tackling unmet needs in gastrointestinal health – starting with Inflammatory Bowel Disease (IBD). Our flagship product, CurQD, combines botanical wisdom with clinical rigor, and is already integrated into 40+ leading U.S. medical centers. The results are backed by various studies, including a randomized controlled trial – the golden standard in clinical validation. In a $21B market underserved by conventional treatment, Evinature brings an effective, science-backed, and scalable alternative into the mainstream that has already treated over 13,000 patients in the U.S.